Target intelligence / Profile preview

Tubulin alpha-3E chain (TUBA3E)

Target
TUBA3E
Molecular classification
Structural protein, Tubulin superfamily, Cytoskeletal protein
01

Overview

Tubulin alpha-3E chain is a **highly conserved alpha-tubulin isoform** that constitutes one half of the heterodimeric tubulin complex, the primary structural component of eukaryotic microtubules. Microtubules are essential for cellular processes including mitosis, intracellular transport, and maintenance of cell shape. TUBA3E is expressed in various tissues and, like other tubulins, polymerizes with beta-tubulin to form dynamic microtubule filaments. Mutations in TUBA3E are associated with disorders such as primary microcephaly and Seckel syndrome, highlighting its essential developmental role. Tubulin family proteins are established targets for many anti-mitotic and anti-cancer therapeutics; however, most approved drugs target tubulin broadly without isoform selectivity, so while TUBA3E is a structural component of the pharmacological target, few interventions are specific to this isoform alone[1][3][2][4].

Other names
Tubulin alpha-3ETubulin alpha 3eTUBA3EAlpha-tubulin 3EDetyrosinated tubulin alpha-3E chain
02

Mechanism of action

Microtubule polymerization/depolymerization inhibition Disruption of microtubule dynamics leading to mitotic arrest and apoptosis (typical for drugs like paclitaxel, colchicine, vincristine targeting tubulin)

03

Biological functions

Microtubule assemblyRegulation of cell structureIntracellular transportCell divisionGTP bindingStructural constituent of cytoskeleton
04

Disease associations

Developmental disorders (e.g., primary microcephaly, microlissencephaly, global developmental delay)Seckel syndromePotential implications in cancer (as with tubulin family proteins in general, though TUBA3E-specific data limited)
05

Safety considerations

Toxicity consistent with disruption of microtubule function: neurotoxicity, myelosuppression, potential off-target effects in dividing and non-dividing cells (e.g., neuropathy with taxanes/vinca alkaloids)
06

Interacting drugs

Colchicine

3 more in the full profile.

07

Biomarkers

Non-specific tubulin isoforms are widely used as cell proliferation/cell cycle biomarkers; direct use of TUBA3E as a clinical biomarker is not well established, though altered tubulin expression can be associated with disease and therapeutic response

Beyond the preview

Go deeper on Tubulin alpha-3E chain (TUBA3E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha-3E chain (TUBA3E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call